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Introduction 
The prognosis for individuals with cystic fibrosis (CF) has improved markedly over the last 50 
years, with most countries now reporting that 50% of the population reach at least 35 years of 
age.[1-3] Despite this improvement, the average age at death is still in the late 20’s and varies 
enormously between CF centres and countries.[4] To further improve the trajectory of lung 
disease, it is critical to identify patients that would benefit most from early intervention.   
Although current markers of disease progression rely on spirometric measures of lung function 
(Forced Expiratory Volume in 1 second; FEV1), it is well recognised that choice of reference 
equation may have a dramatic effect on the apparent rate of decline in lung function. The 
recently published Global Lung Function Initiative (GLI) equations[5]  present a novel 
opportunity to appropriately investigate longitudinal trends in lung function in patients with CF. 
Cross-sectional analysis of data from the UK CF Trust Registry demonstrated important 
differences in interpretation of spirometry results between the internationally endorsed GLI 
equations and those of Knudson[6], Wang[7] and Hankinson[8]. While overall results 
summarised as %predicted FEV1 according to each equation differed by only a few percent, 
individual patient results were quite discrepant, particularly in young children, those over 50 
years, and adolescents. The discrepancies observed during adolescence are of particular concern 
since this population is recognised to be at risk of rapid progression of CF lung disease.[9, 10]   
In this study we aimed to investigate the impact of the GLI equations on estimates of population 
level decline in %predicted FEV1 with age. 
  
Methods 
Data Sources 
Data were extracted from the Toronto CF database containing 1,023 subjects with 27,868 
measurements over 23 years (1990-2013), and the UK CF Registry containing 6,043 subjects 
with 20,013 measurements over 5 years (2007-2011). In the encounter-based Toronto Registry 
patients had an average of 49 observations (range 1-150), while in the annual-based UK Registry 
patients had an average of 4 observations (range 1-5). Patients were included irrespective of 
number of observations, transplant status, age of diagnosis or death. Spirometric outcomes were 
interpreted using %predicted FEV1 calculated from GLI[5], Knudson[6] and Wang-Hankinson[7, 
8]. These were chosen to reflect current practice by many CF Registries. Analyses were limited 
to Caucasian patients > 6 years of age to permit appropriate comparison between equations. 
Patients >30 years of age or with %predicted FEV1 >130% were excluded to minimise the 
impact of survival bias and reduce undue influence of outlier values. 
Statistical Analysis 
A non-linear mixed effects approach using a shape invariant spline curve model was used to 
simultaneously estimate the average change in lung function with age, while adjusting for 
subject-specific random intercepts and slopes, assuming that all patients follow the same 
underlying curve shape.[11] The average change in lung function with age was fitted as a natural 
cubic spline where degrees of freedom (d.f) were chosen to minimise the Bayesian Information 
Criterion (BIC). We compared the complexity (d.f) of the average lung function decline curve 
described by each of the three spirometry reference equations. Analysis was done in the 
statistical program R, using the sitar package.[12]  
Results 
Selecting the simplest model with best fit for each reference equations demonstrated that the 
pattern of FEV1 decline at population level differed according to the reference equations (Figure 
1). GLI models were best fit with steady and near-linear decline starting at younger ages, 
whereas the other equations required more complex models and suggest greater decline during 
adolescence and early adulthood. Similar patterns were observed in the Toronto and UK 
populations (Figure 1A & 1B). Overall >85% of variance was explained by each of the models. 
Thus, while the estimated pattern of lung function decline was influenced by reference equation, 
model fit was not.  
  
Discussion 
The GLI equations demonstrated a near-linear decline throughout childhood with no acceleration 
or deceleration during adolescence. These findings suggest that the well-established adolescent 
decline described at a population level may be an artefact of the spirometry reference equations 
used, rather than reflecting the true clinical course.  The ability to interpret rate of decline in lung 
function accurately is even more important for individual patients in whom inaccurate tracking 
of FEV1 may prompt unnecessary intervention, including invasive procedures and aggressive 
treatments. Equally, these findings suggest that current practice may be missing a critical 
opportunity for intervention earlier in childhood.  
The GLI equations are seamless across all ages, thus avoiding artifactual changes which can 
occur when transitioning from paediatric to adult reference equations.(Kirkby ERJ) Unlike many 
paediatric spirometry equations, the GLI equations take both age and height into account, such 
that predicted values are higher in older than younger individuals of the same height. Thus GLI 
reference equations model growth appropriately during the adolescent period(Quanjer et al erj 
2010, changes in FEV/FVC) and highlight the relative importance of early childhood in 
understanding the progression of CF lung disease. In addition the current study confirms that 
non-linear growth models are appropriate to describe patterns of lung function decline.[13] 
The pattern of %predicted FEV1 decline differed according to the spirometry reference equation 
used. While such differences have been reported previously, this is the first study to use both the 
GLI equations, (which model changes during adolescence more appropriately (Quanjer 2010) 
and employ a non-linear mixed approach to analysis, which takes account of repeated measures 
within individuals over time. The largest discrepancies were observed for the Knudson 
equations, which are a composite of three separate equations, each based on a relatively small 
sample. The Wang-Hankinson equations, which are based on bigger samples with join points 
carefully chosen to minimise discontinuity between equations, match the GLI more closely. 
Nonetheless, use of these older equations may exaggerate the rate of decline during adolescence.  
Limitations 
Our study population was inclusive of patients irrespective of clinical status, therefore the 
observed pattern of lung function decline may not be comparable to previous studies. The 
analyses excluded subjects younger than 6 years of age; however lung function decline may start 
much earlier emphasising the need for early markers of lung disease for this population. In 
addition the analysis was limited to a spirometric outcome, FEV1, which itself may not be 
sensitive enough to detect early pathological changes.  
Our decision to base models on %predicted values is in line with current clinical practice and 
widespread use in epidemiological studies, together with the fact is the only basis on which 
results can be readily calculated when using the Knudson or Wang-Hankinson equations. 
However, this may introduce an age, sex and height bias, especially when interpreting results 
from adults, which can be avoided by alternative ways of using FEV1 (Miller erj),  including the 
use of  z-scores, (Stanojevic breathe ) which can be readily calculated when using GLI equations. 
To further investigate the potential benefits of these alternative approaches when interpreting 
longitudinal changes, it will be essential to link changes in lung function to clinical outcomes 
within individuals.  Whereas the clinical interpretation of change over time in %predicted FEV1 
(including its inherent challenges) is familiar to the CF community, longitudinal changes in z 
scores are less well understood and require further detailed analysis which is beyond the scope of 
the current brief report.  
Conclusion 
These findings challenge previously held beliefs about population trends in disease progression 
in patients with CF, particularly the rapid FEV1 decline during adolescence. It is crucial that we 
better understand the nature and relationship of disease progression, as inaccurate tracking of 
lung function will make targeted intervention for at-risk individuals less effective.  
  
Figure Legend 
Figure 1. Overall pattern of %predicted FEV1 with age at the population level as defined by three 
spirometric reference equations, GLI (solid line), Wang-Hankinson (dashed line) and Knudson 
(dotted line). Data are presented for the Toronto CF database (A) and the UK CF Registry (B). In 
the Toronto dataset GLI and Wang-Hankinson equations show steady rate of decline in 
childhood, whereas the Knudson equations show periods of accelerated decline in adolescence. 
In the UK dataset, both Wang-Hankinson and Knudson equations show periods of accelerated 
decline in adolescence, with GLI equations showing steady decline starting in childhood  
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